MLchartDataset catalogue

Phase 2 trial

Term · Environment · MLC-T-ENV-030773

Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects.

Table 1. Record
IdentifierMLC-T-ENV-030773
FieldEnvironment
SubjectResearch
Referencesafter FDA CDER handbook, ICH E8; CDISC-GLOSS
Record as JSON
{
  "id": "MLC-T-ENV-030773",
  "term": "Phase 2 trial",
  "field": "Environment",
  "term_source": "Phase 2 Trial",
  "definition": "Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects.",
  "subject": "Research",
  "references": [
    "after FDA CDER handbook, ICH E8; CDISC-GLOSS"
  ],
  "url": "https://mlchart.com/terminology/environment/phase-2-trial/"
}

Record 20,289 of 29,894 in Environment terminology (MLC-0121). Request the full dataset.